Continuous Intraperitoneal Insulin Infusion for People With Type 1 Diabetes: A Literature Review and International Position Statement

Continuous intraperitoneal insulin infusion has comparable or better glucose outcomes vs CSII and may reduce hypoglycaemia frequency, including severe episodes

Intraperitoneal insulin may be considered for children and adults with T1D on optimised intensive insulin therapy in whom subcutaneous insulin has failed due to lipoatrophy, -dystrophy or -hypertrophy, local allergy, subcutaneous insulin resistance or co-existing skin conditions

Intraperitoneal insulin may also be considered for people with T1D with severe needle-phobia, those being considered for islet cell or pancreatic transplantation, or where transplantation is not available